Lonza | LONN - Gross Profit On Sales



Lonza reported CHF1.04B in Gross Profit on Sales for its fiscal semester ending in December of 2024.


Gross Profit On Sales Change Date
Akzo Nobel EUR 1.04B 10M Jun/2025
Alcon AG USD 1.39B 5M Jun/2025
Almirall EUR 191.9M 185.49M Mar/2025
AstraZeneca USD 11.98B 637M Jun/2025
BASF EUR 4.18B 675M Jun/2025
Bayer EUR 6.38B 1.74B Jun/2025
Beiersdorf EUR 1.54B 1.16B Jun/2025
Covestro EUR 552M 87M Jun/2025
Demant DKK 8.55B 33M Jun/2025
Fresenius EUR 1.46B 47M Jun/2025
Fresenius Medical Care EUR 1.22B 31M Jun/2025
Geberit CHF 649.4M 100.1M Mar/2025
Genmab DKK 868M 195M Jun/2025
Givaudan CHF 823M 575M Jun/2024
GlaxoSmithKline GBP 5.82B 229M Jun/2025
GN Store Nord DKK 2.31B 123M Jun/2025
Hikma Pharmaceutical USD 692M 64M Dec/2024
Johnson Matthey GBP 490M 81M Mar/2025
Merck EUR 3.03B 118M Jun/2025
Novartis USD 11.51B 1.12B Jun/2025
Philips EUR 2.01B 162M Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024
Sanofi EUR 7.74B 26M Jun/2025
Sika AG CHF 1.61B 1.6B Jun/2024
Smith & Nephew USD 2.09B 19M Jun/2025
Solvay EUR 252M 0 Jun/2025
UCB EUR 2.46B 520M Dec/2024